Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131287
Status:
COMPLETED
Last Update Posted:
2010-01-05
First Post:
2005-08-16
Brief Title:
The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus DM
Sponsor:
ECbiotech Taiwan
Organization:
ECbiotech Taiwan
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine whether the extract of the Agaricus blazei Murill mushroom is effective in the supplementary treatment of type II DM patients
Detailed Description:
The researchers have the animal model that the extract of the Agaricus blazei Murill mushroom is effective in the treatment of type II DM mice conducted on 2002 The dose effects were also found The researchers conducted the pilot study also showing the same effects in 2003 So the researchers designed this trial The elixir of the Agaricus blazei Murill mushroom is popular in Taiwan for chronic diseases such as type II DM
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None